[144] Sera Prognostics, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 filing reports a proposed sale of 6,447 Class A Common shares of Sera Prognostics (SERA) through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $16,377. The record lists 38,061,868 shares outstanding. The securities were acquired via restricted stock unit vesting from the issuer on 08/08/2025, with the same date shown as the approximate sale date.
The filing also discloses sales in the past three months by Benjamin Jackson: 7,084 shares sold on 05/08/2025 for $17,303 and 965 shares sold on 06/10/2025 for $1,433. Several standard filer contact fields (CIK/CCC and named account fields) are not populated in the provided content.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 notice for a small RSU-derived sale; amounts are immaterial to overall share count.
The filing documents a proposed sale of 6,447 shares valued at $16,377, against 38,061,868 shares outstanding, representing roughly 0.017% of the outstanding stock. Prior three-month disposals total 8,049 shares for $18,736. These figures indicate small, routine insider liquidity rather than a material equity shift. The filing provides transaction dates, broker details, and vesting provenance (RSU vesting), supporting compliance and transparency.
TL;DR: The notice is a standard compliance disclosure showing RSU vesting and planned sales; governance disclosure appears complete for Rule 144 purposes.
The form identifies the broker (Morgan Stanley Smith Barney), acquisition method (Restricted Stock Unit Vesting on 08/08/2025), and prior sales by Benjamin Jackson in May and June 2025 with gross proceeds. While some filer header fields are blank in the provided extract, the core Rule 144 sale and acquisition details are present, fulfilling the primary disclosure requirements for proposed insider sales.